Côme Lepage Selected Research

Côme Lepage Research Topics

Disease

16	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 03/2008
12	Neoplasms (Cancer) 01/2023 - 08/2013
7	Colonic Neoplasms (Colon Cancer) 10/2021 - 08/2014
5	Disease Progression 04/2024 - 02/2018
5	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2014
4	Adenocarcinoma 04/2024 - 01/2015
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 01/2021
4	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 11/2011
3	Neuroendocrine Carcinoma 01/2023 - 02/2018
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2020
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 03/2024 - 11/2014
2	Microsatellite Instability 10/2023 - 01/2021
2	Neutropenia 01/2023 - 03/2021
2	Asthenia 01/2023 - 03/2021
2	Inflammation (Inflammations) 12/2022 - 11/2021
2	Primitive Neuroectodermal Tumors (PNET) 01/2022 - 12/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2014
1	Ischemic Stroke 01/2023
1	Jaundice (Icterus) 01/2023
1	Anal Canal Carcinoma 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 07/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2022
1	Dementia (Dementias) 07/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Frailty 01/2022
1	Vipoma (WDHA) 12/2021
1	Liver Failure 03/2021
1	Thrombocytopenia (Thrombopenia) 03/2021
1	Hemorrhage 03/2021
1	Hypersensitivity (Allergy) 07/2019
1	Hyperbilirubinemia 11/2014
1	Complementation Group D1 Fanconi Anemia 08/2014
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2012
1	Fatty Liver 04/2012
1	False Aneurysm (Pseudoaneurysm) 09/2008

Drug/Important Bio-Agent (IBA)

7	Fluorouracil (Carac)FDA LinkGeneric 04/2024 - 08/2014
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2022 - 08/2014
5	PlatinumIBA 04/2024 - 02/2018
4	Leucovorin (Folinic Acid)FDA Link 04/2024 - 08/2014
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
3	Irinotecan (Camptosar)FDA LinkGeneric 04/2024 - 01/2020
3	Bevacizumab (Avastin)FDA Link 01/2023 - 02/2018
3	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 02/2018
3	Circulating Tumor DNAIBA 01/2022 - 01/2020
3	Sunitinib (Sutent)FDA Link 01/2022 - 03/2021
3	Gemcitabine FDA Link 01/2020 - 11/2014
3	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 11/2014
3	Ethiodized Oil (Ethiodol)FDA Link 01/2018 - 11/2011
2	avelumabIBA 10/2023 - 01/2021
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023 - 01/2023
2	ElementsIBA 12/2022 - 01/2022
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 12/2021
2	Everolimus FDA Link 01/2022 - 12/2021
2	Cetuximab (Erbitux)FDA Link 10/2020 - 10/2018
2	Carboplatin (JM8)FDA LinkGeneric 07/2019 - 02/2018
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018 - 08/2013
2	Calcibiotic Root Canal SealerIBA 01/2018 - 08/2014
2	Dihydrotachysterol (AT 10)IBA 01/2015 - 03/2008
2	GuaiacIBA 12/2014 - 10/2008
2	AnthracyclinesIBA 08/2013 - 11/2011
1	afliberceptIBA 04/2024
1	durvalumabIBA 04/2024
1	tremelimumabIBA 04/2024
1	spleen fibrinolytic proteinase (human) (SFP)IBA 03/2024
1	Panitumumab (Vectibix)FDA Link 01/2023
1	InterferonsIBA 12/2022
1	Donepezil (Aricept)FDA LinkGeneric 07/2022
1	Cholinesterases (Cholinesterase)IBA 07/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	RamucirumabIBA 01/2022
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 12/2021
1	BilirubinIBA 03/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021
1	Carcinoembryonic AntigenIBA 10/2020
1	Capecitabine (Xeloda)FDA Link 10/2020
1	chemotactic factor inactivatorIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	SaltsIBA 07/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	LIDAIBA 01/2018
1	EmulsionsIBA 01/2018
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 04/2012
1	AdiponectinIBA 04/2012
1	AdipokinesIBA 04/2012
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2011

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 04/2024 - 10/2013
7	Therapeutics 01/2022 - 05/2016
5	Radiotherapy 11/2021 - 10/2013
4	Adjuvant Chemotherapy 10/2018 - 08/2014
2	Chemoradiotherapy 01/2023 - 11/2014
2	Induction Chemotherapy 10/2020 - 01/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023
1	Secondary Prevention 01/2022
1	Neoadjuvant Therapy 01/2022
1	Contraindications 01/2021
1	Adjuvant Chemoradiotherapy 01/2014
1	Time-to-Treatment 08/2013
1	Splenectomy 09/2008